These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10418904)

  • 1. Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax).
    Cho HW; Howard CR
    Vaccine; 1999 Jun; 17(20-21):2569-75. PubMed ID: 10418904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of an inactivated vaccine against hantaviruses.
    Cho HW; Howard CR; Lee HW
    Intervirology; 2002; 45(4-6):328-33. PubMed ID: 12602351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety and immunogenicity of inactivated bivalent EHF vaccine in humans].
    Liu W; Xu X; Ruan Y; Weng S; Liu W; Zhou W; Dong G; Gu H; Zhu Z; Xu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):445-7. PubMed ID: 11860832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of immune responses to vaccine against haemorrhagic fever with renal syndrome in healthy adults aged 16-60 years: results from an open-label2-year follow-up study.
    Zheng Y; Zhou BY; Wei J; Xu Y; Dong JH; Guan LY; Ma P; Yu PB; Wang JJ
    Infect Dis (Lond); 2018 Jan; 50(1):21-26. PubMed ID: 28703073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary human trial of inactivated golden hamster kidney cell (GHKC) vaccine against haemorrhagic fever with renal syndrome (HFRS).
    Song G; Huang YC; Hang CS; Hao FY; Li DX; Zheng XL; Liu WM; Li SL; Huo ZW; Huei LJ
    Vaccine; 1992; 10(4):214-6. PubMed ID: 1348595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to inactivated vaccine in people naturally infected with hantaviruses.
    Lu Q; Zhu Z; Weng J
    J Med Virol; 1996 Aug; 49(4):333-5. PubMed ID: 8877768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study on antibody levels of vaccination group and control group after 4 years of immunized with type B inactivated vaccine against hemorrhagic fever with renal syndrome].
    Ruan Y; Liu W; Xu X; Weng SQ; Shao SK; Zhou WQ; Teng Z; Gu HX; Zhu ZY; Xu ZY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):274-6. PubMed ID: 11986705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine.
    Yoo YC; Yoshimatsu K; Koike Y; Hatsuse R; Yamanishi K; Tanishita O; Arikawa J; Azuma I
    Vaccine; 1998; 16(2-3):216-24. PubMed ID: 9607033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation on inactivated epidemic hemorrhagic fever tissue culture vaccine in humans.
    Zhu ZY; Tang HY; Li YJ; Weng JQ; Yu YX; Zeng RF
    Chin Med J (Engl); 1994 Mar; 107(3):167-70. PubMed ID: 7916278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Effectiveness of Inactivated Hantavirus Vaccine Against Hemorrhagic Fever With Renal Syndrome.
    Jung J; Ko SJ; Oh HS; Moon SM; Song JW; Huh K
    J Infect Dis; 2018 Apr; 217(9):1417-1420. PubMed ID: 29373686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax™) in healthy adults.
    Song JY; Woo HJ; Cheong HJ; Noh JY; Baek LJ; Kim WJ
    Vaccine; 2016 Mar; 34(10):1289-95. PubMed ID: 26826547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term persistence of anti-hantavirus antibodies in sera of patients undergoing hemorrhagic fever with renal syndrome and subjects vaccinated against the disease.
    Zheng Y; Wei J; Zhou BY; Xu Y; Dong JH; Guan LY; Ma P; Yu PB; Wang JJ
    Infect Dis (Lond); 2016 Apr; 48(4):262-266. PubMed ID: 26654580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The changes in serum antibody level after immunization with HFRS vaccine].
    Gong Z; Weng J; Zhao Z; Lan J; Chen Y; Lin C; Fu G; Zhu Z; Xia J; Ji Q; Xu J; Wang C; Yu X; Wang W; Fang C
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Nov; 34(6):351-3. PubMed ID: 11860948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy.
    Jiang DB; Zhang JP; Cheng LF; Zhang GW; Li Y; Li ZC; Lu ZH; Zhang ZX; Lu YC; Zheng LH; Zhang FL; Yang K
    Antiviral Res; 2018 Feb; 150():174-182. PubMed ID: 29273568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary humoral immune responses to formalin inactivated hemorrhagic fever with renal syndrome vaccine (Hantavax): consideration of active immunization in South Korea.
    Sohn YM; Rho HO; Park MS; Kim JS; Summers PL
    Yonsei Med J; 2001 Jun; 42(3):278-84. PubMed ID: 11456392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of inactivated vaccine containing cyto-hemagglutinin against epidemic hemorrhagic fever in rabbits.
    Zhu ZY; Tang HY; Li YJ; Weng JQ; Fu GM
    Chin Med J (Engl); 1989 Aug; 102(8):602-5. PubMed ID: 2576866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of inactivated vaccine against virus causing haemorrhagic fever with renal syndrome.
    Yamanishi K; Tanishita O; Tamura M; Asada H; Kondo K; Takagi M; Yoshida I; Konobe T; Fukai K
    Vaccine; 1988 Jun; 6(3):278-82. PubMed ID: 3138829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses.
    de Carvalho Nicacio C; Gonzalez Della Valle M; Padula P; Björling E; Plyusnin A; Lundkvist A
    J Virol; 2002 Jul; 76(13):6669-77. PubMed ID: 12050380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area.
    Fehér O; Bakonyi T; Barna M; Nagy A; Takács M; Szenci O; Joó K; Sárdi S; Korbacska-Kutasi O
    Vet Immunol Immunopathol; 2020 Sep; 227():110087. PubMed ID: 32629300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.
    Li Z; Zeng H; Wang Y; Zhang Y; Cheng L; Zhang F; Lei Y; Jin B; Ma Y; Chen L
    Hum Vaccin Immunother; 2017 Apr; 13(4):802-807. PubMed ID: 27824286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.